Immunohistochemical techniques in prion diseases;Técnicas de inmunohistoquímica en las enfermedades por priones

Revista de Neurologia

Volumn 31, Issue 2, 2000, Pages 156-159

  Gonzalo Pascual, I ^a   Cuadrado Corrales, N ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

Author keywords

Immunohistochemistry; Prion diseases; Prion protein

Indexed keywords

ARTICLE; CLASSIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PRION; PRION DISEASE;

HUMANS; IMMUNOHISTOCHEMISTRY; PRION DISEASES; PRIONS;

EID: 0034674830     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3102.99387     Document Type: Article

References (59)

1. Brown P, Wolff A, Gajdusek DC. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 1990; 40: 887-90.
2. Picardo P, Safar J, Ceroni M, Gajdusek DC, Gibbs CJ. Immunohistochemical localization of prion protein in spongiform encephalopathies and normal brain tissue. Neurology 1990; 40: 518-22.
3. Guiroy DC, Yanaghihara R, Gajdusek DC. Localization of amyloidogenic proteins and sulfated glycosaminoglycans in nontransmissible and transmissible cerebral amyloidoses. Acta Neuropathol 1991; 82: 87-92.
4. Diringer H, Rahn HC, Bode L. Antibodies to protein of scrapie-associated fibrils. Lancet 1984; ii: 345.
5. Kascsack RJ, Rubenstein R, Merz PA. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 1987; 61: 3688-93.
6. DeArmond SJ, Mobley WC, DeMott DL, Barry RA, Beckstead JH, Prusiner SB. Changes in the localization of brain prion proteins during scrapie infection. Neurology 1987; 37: 1271-80.
7. Casaccia P, Ladogana A, Xi YG, Pocchiari M. Levels of infectivity in the blood throughout the incubation period of hamsters peripherally injected with scrapie. Arch Virol 1989; 108: 145-50.
8. Sc)-specific epitope defined by a monoclonal antibody. Nature 1997; 6: 390: 74-7.
9. Bell JE, Gentleman SM, Ironside JW, McCardle L, Lantos PL, Doey L, et al. Prion protein immunocytochemistry-UK five centre consensus report. Neuropathol Appl Neurobiol 1997; 23: 26-35.
10. Hayward PAR, Bell JE, Ironside JW. Prion protein immunocytochemistry: reliable protocols for the investigation of Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1994; 20: 375-83.
11. Doi-Yi R, Kitamoto T, Tateishi J. Immunoreactivity of cerebral amyloidosis is enhanced by protein denaturation treatments. Acta Neuropathol 1991; 82: 260-5.
12. Powers JM, Liu Y, Hair LS, Kascsack RJ, Lewis LD, Levy LA. Concomitant Creutzfeldt-Jakob and Alzheimer diseases. Acta Neuropathol 1991; 83: 95-8.
13. Muramoto T, Kitamoto T, Koga H, Tateishi J. The coexistence of Alzheimer's disease and Creutzfeldt-Jakob disease in a patient with dementia of long duration. Acta Neuropathol 1992; 84: 686-9.
14. Hansen LA, Masliah E, Terry RD, Mirra SS. A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol 1989; 78: 194-201.
15. Ironside JW, McCardle L, Hayward PAR, Bell JE. Ubiquitin immunocytochemistry in human spongiform encephalopathies. Neuropathol Appl Neurobiol 1993; 19: 134-40.
16. Tomlinson BE. Creutzfeldt-Jakob disease. In Adams JH, Duchen LW, eds. Greenfield's neuropathology. 5 ed. London: Edward Arnold; 1992. p. 1366-75.
17. Bell JE, Ironside JW. Neuropathology of spongiform encephalopathies in humans. Br Med Bull 1993; 49: 738-77.
18. Goodbrand IA, Ironside JW, Nicolson D, Bell JE. Prion protein accumulation in the spinal cords of patients with sporadic and growth hormone associated Creutzfeldt-Jakob disease. Neurosci Lett 1995; 183: 127-30.
19. Kitamoto T, Muramoto T, Mohri S, Doh-ura K, Tateishi J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J Virol 1991; 65: 6292-5.
20. Askanas V, King EW, Alvarez RB. Light and electron microscopic localisation of B-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol 1992; 141: 31-6.
21. Askanas V, Bilak M, Engel WK, Alvarez RB, Tome F, Leclerc A. Prion protein is abnormally accumulated in inclusion-body myositis. Neuroreport 1993; 5: 25-8.
22. Watanabe R, Duchen LW. Cerebral amyloid in human prion disease. Neuropathol Appl Neurobiol 1993; 19: 253-60.
23. Ironside JW, Bell JE. Pathology of prions disease. In Collinge J, Palmer MS, eds. Prion Diseases. 1 ed. New York: Oxford University Press; 1997. p. 57-87.
24. DeArmond SJ, Prusiner SB. Prion diseases. In Graham DI, Lantos PL, eds. Greenfield's neuropathology. 6 ed. New York: Oxford University Press; 1997. p. 235-71.
25. Kitamoto T, Doh-ura K, Muramoti T, Miyazono M, Tateishi J. The primary structure of the prion protein influences the distribution of abnormal prion protein in central nervous system. Am J Pathol 1992; 141: 271-7.
26. Kitamoto T, Shin RW, Doh-ura K, Tomokane N, Miyazono M, Muramoto T, Tateishi J. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 1992; 140: 1285-94.
27. Diedrich JF, Bendheim PE, Kim YS, Carp RI, Haase AT. Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc Nat Acad Sci U S A 1991; 88: 375-9.
28. Klatzo I, Gajdusek DC, Zigas V. Pathology of Kuru. Lab Invest 1959; 8: 799-847.
29. Hashimoto K, Mannen T, Nukina N. Immunohistochemical study of kuru plaques using antibodies against synthetic prion protein peptides. Acta Neuropathol 1992; 83: 613-7.
30. Hainfellner JA, Liberski PP, Guiroy DC, Cervenakova L, Brown P, Gajdusek DC, et al. Pathology and immunocytochemistry of a Kuru brain. Brain Pathol 1997; 7: 547-53.
31. Amano N, Yagishita S, Yokio S, Itoh Y, Kinoshita J, Mizutani T, et al. Gerstmann-Sträusler syndrome- a variant type: amyloid plaques and Alzheimer's neurofibrillary tangles in cerebral cortex. Acta Neuropathol 1992; 84: 15-23.
32. Ghetti B, Tagliavini F, Masters CL, Beyreuther K, Giaccone G, Verga L, et al. Gerstmann-Sträusler-Scheinker disease. II neurofibrillary tangles and plaques with PrP-amyloid coexists in an affected family. Neurology 1989; 39: 1453-61.
33. Nochlin D, Sumi SM, Bird TD, Snow AD, Leventhal CM, Beyreuther K, et al. Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Sträusler syndrome. Neurology 1989; 39: 910-8.
34. CJD in the nervous system. Brain Pathol 1995; 5: 33-41.
35. Berciano J, Díez C, Polo JM, Pacual J, Figols J. CT appearance of panencephalopathic and ataxic type of Creutzfeldt-Jakob disease. J Comput Assis Tomogr 1991; 15: 332-4.
36. Kitamoto T, Tateishi J, Sato Y. Immunohistochemical verification of senile and kuru plaques in Creutzfeldt-Jakob disease and the allied disease. Ann Neurol 1988; 24: 537-42.
37. Shintaku M, Ogura J, Terashima A. 'Neuritic conglomerates' in the cerebral cortex of a patient with Creutzfeldt-Jakob disease. Acta Neuropathol 1996; 92: 319-23.
38. Kitamoto T, Tateishi J. Immunohistochemical confirmation of Creutzfeldt-Jakob disease with a long clinical course with amyloid plaque core antibodies. Am J Pathol 1988; 131: 435-43.
39. Lantos PL, McGill IS, Janota I, Doey LJ, Collinge J, Bruce MT, et al. Prion protein immunocytochemistry helps to establish the true incidence of prions diseases. Neurosci Lett 1992; 147: 67-71.
40. Kretzschmar HA, Kitamoto T, Doerr-Schott J, Mehraein P, Tateishi J. Diffuse deposition of immunohistochemically labeled prion protein in the granular layer of the cerebellum in a patient with Creutzfeldt-Jakob disease. Acta Neuropathol 1991; 82: 536-40.
41. Hoque MZ, Kitamoto T, Furukawa H, Muramoto T, Tateishi J. Mutation in the prion protein gene at codon 232 in japanese patients with Creutzfeldt-Jakob disease: a clinicopathological, immunohistochemical and transmission study. Acta Neuropathol 1996; 92: 441-6.
42. Weller RO, Steart PV, Powell-Jackson JD. Pathology of Creutzfeldt-Jakob disease associated with pituitary-derived human growth hormone administration. Neuropathol Appl Neurobiol 1986; 12: 117-29.
43. Billet de Villemeur TB, Deslys JP, Pradel A, Soubrie C, Alperovitch A, Tardieu M, et al. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology 1995; 47: 690-5
44. Brown P, Preece MA, Will RG. 'Friendly fire' in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992; 340: 24-7.
45. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-5.
46. Gambrtti P, Parchi P, Petersen RB, Chen SG, Lugaresi E. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol 1995; 5: 43-51.
47. Manetto V, Medori R, Cortelli P, Montagna P, Tinuper P, Baruzzi A, et al. Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology 1992; 42: 312-9.
48. Medori R, Tritschler HJ, LeBlanc A, Villare F, Manetto V, Chen HY, et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992; 326: 444-9.
49. Gambetti P, Peterson R, Monari L, Tabaton M, Autillo-Gambetti L, Cortelli P, et al. Fatal familial insomnia and the widening spectrum of prion diseases. Br Med Bull 1993; 49: 980-94.
50. Kitamoto T, Tateishi J. Human prion diseases with variant prion protein. Philos Trans R Soc Lond B Biol Sci 1994; 343: 391-8.
51. Castellani R, Parchi P, Stahl J, Capellari S, Cohen M, Gambetti. Early pathologic and biochemical changes in Creutzfeldt-Jakob disease: study of brain biopsies. Neurology 1996; 46: 1690-93.
52. MacDonald T, Sutherland K, Ironside JW. Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1996; 22: 285-92.
53. Mühleisen H, Gehrmann J, Meyermann R. Reactive microglia in Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1995; 21: 505-17.
54. Brown DR, Kretzschmar HA. Microglia and prion disease: a review. Histol Histopathol 1997; 12: 883-92.
55. Brown P, Cervenakova L, Goldfarb LG, McCombie WR, Rubestein R, Will RG, et al. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine.
56. Collinge J, Palmer MS, Dryden AJ. Genetic Predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991; 337: 1441-2
57. Schulz-Schaeffer WJ, Giese A Windl O, Kretzschmar HA. Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease. Clin Neuropathol 1996; 15: 353-5.
58. De Silva R, Ironside JW, McCardle L, Esmonde T, Bell J, Will R, et al. Neuropathological phenotype and prion protein genotype correlation in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 1994; 179: 50-2.
59. Collinge J, Slide KCL, Meads J, Ironside J, Hill FA. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383: 685-90.